据南方周末报道,司美格鲁肽是一款以减重功效闻名全球的控糖药物,在国内仅获批控糖和心血管“双适应症”,对象是成人2型糖尿病
06/13 18:29
06/13 18:26
06/13 18:25
06/13 18:23
06/13 18:20
06/13 18:16
06/13 18:09
06/13 12:07
06/13 12:06